Ed Kaye, Stoke’s longtime leader, will be replaced by former Vertex executive Ian Smith. Elsewhere, all 12 drugmakers ...

Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

As a drugmaker depending heavily on sales of both branded and non-branded products, Teva has said that it is uniquely affected by how medicines are selected for the Medicare drug price negotiation | ...

Republicans eager to offset the cost of cutting taxes may see lower Medicare spending on outpatient care as a source of budgetary savings.

Joe Biden’s presidency is mercifully over. However, his damaging policies are still with us — as a recent announcement from ...

Just before the inauguration, the outgoing Biden administration announced 15 new medications that'll be subject to government ...

In today's Pharmalittle roundup, we're reading about Medicare negotiations, U.K. drug rebates rising, and more.

The selected drugs account for approximately $41 billion in total spending under Medicare Part D between November 2023 and October 2024, or about 14% of Medicare Part D's prescription drug costs, ...

One of the law’s worst provisions is the so-called “ pill penalty .” Under this rule, newly approved small-molecule drugs — ...

After spending 50 years in the private sector where cost reduction opportunities are near infinite in number, I believe the ...

President Trump’s Justice Department will defend Biden’s Inflation Reduction Act and its dangerous price controls on ...

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...